Pilot Study of a Catheter-based Ultrasound Hyperthermia System
Stopped early · Not applicable
Conditions studied: Cervical Cancer, Prostate Cancer
In brief
RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above normal body temperature. Ultrasound energy may be able to kill tumor cells by heating up the tumor cells without affecting the surrounding tissue. Implant radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving ultrasound hyperthermia therapy after implant radiation therapy may kill more tumor cells. PURPOSE: This clinical trial is studying ultrasound hyperthermia therapy to see how well it works after implant radiation therapy in treating patients with Stage III/IV cancer of the cervix or prostate cancer with a rising prostate specific antigen (PSA) after prior local therapy.
Key facts
- Study ID
- NCT00911079
- Run by
- University of California, San Francisco
- People needed
- 13
- Starts
- 2009-12-18
- Expected to finish
- 2020-07-23
- Last updated by the study team
- 2021-07-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who are to be given HDR brachytherapy for treatment of solid tumor of the following:
- Cervical cancer Stage III or IV OR
- Prostate cancer (with rising prostate specific antigen after prior local therapy)
- Age >=18 years
- Eligible for brachytherapy as determined per clinical standard of care.
- Ability to give written informed consent and willingness to comply with the requirements of the protocol
You may not qualify if…
- Patients who are not candidates for HDR brachytherapy
- Any condition that compromises compliance with the objectives and procedures of this protocol, as judged by the principal investigator
Where it is running
- University of California, San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.